Top 10 Cancer Research Stories of 2019

Members of the U-M Rogel Cancer Center continue to push the boundaries of cancer prevention, diagnosis and treatment.

5:00 AM

Author | Ian Demsky

Cancer round up image

 

Every day of the year, scientists at the University of Michigan Rogel Cancer Center conduct research to deepen our understanding of cancer and to improve care for cancer patients.

"This year Rogel Cancer Center researchers have continued to illuminate new aspects of cancer biology, move promising drug discovery projects toward the clinic and analyze outcomes data to improve care delivery," says Director Eric Fearon, M.D., Ph.D., Emanuel N. Maisel Professor of Oncology at Michigan Medicine. "We are home to more than 340 faculty members drawn from 53 academic departments across nine schools and colleges at U-M. I'm extremely proud of all of their work on behalf of our patients and survivors and others across the globe whose lives will one day be touched by cancer."

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunesGoogle Play and Stitcher

Fearon stressed that these discoveries wouldn't be possible without the ongoing support of federally funded agencies including the National Cancer Institute and National Institutes of Health, as well as the support of organizations like the American Cancer Society and generous philanthropic funding.

"It's important to understand that breakthroughs in cancer don't happen in a vacuum and, in fact, require substantial societal investment," he adds. "We are grateful to all of the organizations and individuals who make these forward strides possible."

Breakthroughs in cancer don't happen in a vacuum and, in fact, require substantial societal investment.
Eric Fearon, M.D., Ph.D.

Below are our top 10 research stories from 2019:

U-M researchers characterized three ways in which the gene FOXA1 mutates to trigger prostate cancer.

An international clinical trial showed the promise of immune treatment against HPV infections that lead to cervical cancer.

The largest study of its kind found that societal factors and access to quality care, rather than genetics, underlies higher prostate cancer mortality rates for black men.

An early clinical trial at U-M found that a Wee1 inhibitor, combined with radiation and gemcitabine, is safe and potentially effective in pancreatic cancer treatment.

A potent and selective degrader of the transcription factor STAT3 offers a new approach to a previously "undruggable" target.

Michigan-led research presented a new way of uncovering predictive biomarkers when data from large randomized trials aren't available.

While it plays a protective role in other diseases, knocking out NLRP6 in mice led to better outcomes and less-severe symptoms after a bone marrow transplant.

A U-M study was the first to define how a little-known type of cell death impacts tumor cells and immune cells.

A genetic mutation makes a glioma subtype resistant to radiation, but a U-M study found a potential way around it using currently available drugs.

Speaking directly with a pathologist could help patients better understand their diagnosis and feel empowered, a survey of patient sentiment found.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Stay up to date on the latest cancer research from the U-M Rogel Cancer Center on Twitter at @UMRogelCancer or visit rogelcancercenter.org/news.


More Articles About: Lab Report Cancer Research Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

This article is from the Health Lab digital publication.

Media Contact Public Relations

Department of Communication at Michigan Medicine

MichMedmedia@med.umich.edu

734-764-2220

Newsletter

Get a weekly digest of medical research and innovation, straight to your inbox.

Subscribe
Featured News & Stories cancer cells microscope blue green
Health Lab
Certain gene signaling rewires tumors after immunotherapy
For some patients, immunotherapy furthers tumor progression instead of halting it. What distinguishes those who benefit from those who don’t?
Multicolored rainbow brain cross section on black background
Health Lab
New clues toward treating pediatric brain tumors harboring epigenetic mutation
Inhibition of STAT3 signaling may improve survival in those with H3.3G34R/V mutant gliomas, animal studies suggest.
 Metformin Molecular Model
Health Lab
Common diabetes drug promising against rare childhood brain tumor in laboratory studies
What if a common diabetes medication could help fight a rare type of childhood brain cancer? Recent lab studies reveal metformin shows promising results in suppressing specific tumor types.
doctor and researchers in lab coat and white coat in lab looking at syringe injection
Health Lab
Researchers uncover way to harness the power of immunotherapy for advanced prostate cancer
A protein called PIKfyve impacts multiple processes involved in metabolism and cell death; blocking it is key to making immunotherapy work in prostate cancer.
cancer cell in orange under microscope
Health Lab
Researchers Discover First Immune Stimulating Long Noncoding RNA Involved in Body's Response to Cancer
The findings in human cells and animal models suggest potential approaches to improve immunotherapy treatment against cancer.
Health Lab
New Clues to Classic Cancer Target Found in Immune Cells
Scientists have long sought to target the interaction between the proteins p53 and Mdm2 in tumor cells, but their interaction in immune cells may be just as important.